Dow Up 1.13% Nasdaq Up 1.41%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.36 Down 0.09(2.02%) 4:00PM EDT
|After Hours : 4.26 Down 0.10 (2.29%) 4:34PM EDT
Prev Close:4.45
Open:4.50
Bid:4.26 x 200
Ask:4.50 x 500
1y Target Est:7.00
Beta:-3.58
Next Earnings Date: 3-Nov-14ARNA Earnings announcement
Day's Range:4.35 - 4.50
52wk Range:3.26 - 7.97
Volume:4,202,316
Avg Vol (3m):4,188,820
Market Cap:958.48M
P/E (ttm):N/A
EPS (ttm):-0.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARNA

Comparison

Symbol% ChgMkt Cap
ARNADown 2.02%958.48M
GSKUp 0.78%109.36B
OREXDown 1.69%497.49M
RHHBYDown 1.00%250.12B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):32.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.32
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):0.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback